Cyclin-dependent kinase inhibitor 1B (CDKN1B) gene variants in AIP mutation-negative familial isolated pituitary adenoma kindreds.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Endocrine-Related Cancer

• Publication date

  2012-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1530/ERC-11-0362PMID 22291433
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009.

  2012cited by this paper
• CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011.

  2012cited by this paper
• High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas.

  2011cited by this paper
• Somatic mutation and germline sequence abnormalities in CDKN1B, encoding p27Kip1, in sporadic parathyroid adenomas.

  2011cited by this paper
• Genetic susceptibility in pituitary adenomas: from pathogenesis to clinical implications

  2011cited by this paper
• Sequence analysis of the CDKN1B gene in patients with premature ovarian failure reveals a novel mutation potentially related to the phenotype.

  2011cited by this paper
• Prevalence of pituitary adenomas: a community‐based, cross‐sectional study in Banbury (Oxfordshire, UK)

  2010cited by this paper
• Characterization of Aryl Hydrocarbon Receptor Interacting Protein (AIP) Mutations in Familial Isolated Pituitary Adenoma Families

  2010cited by this paper
• Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study.

  2010cited by this paper
• A Novel Germline CDKN1B Mutation Causing Multiple Endocrine Tumors: Clinical, Genetic and Functional Characterization

  2010cited by this paper
• p27kip1: A New Multiple Endocrine Neoplasia Gene?

  2010cited by this paper
• Assessment of p27 (cyclin‐dependent kinase inhibitor 1B) and aryl hydrocarbon receptor‐interacting protein (AIP) genes in multiple endocrine neoplasia (MEN1) syndrome patients without any detectable MEN1 gene mutations

  2009cited by this paper
• Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states.

  2009cited by this paper
• Post-translational regulation of the tumor suppressor p27KIP1

  2008cited by this paper
• Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia.

  2007cited by this paper
• Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families.

  2007cited by this paper
• Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutations

  2007cited by this paper
• Clinical characterization of familial isolated pituitary adenomas.

  2006cited by this paper
• Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans

  2006cited by this paper
• High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium.

  2006cited by this paper
• Pituitary Adenoma Predisposition Caused by Germline Mutations in the AIP Gene

  2006cited by this paper
• A novel p27 gene mutation in a case of unclassified myeloproliferative disorder.

  2005cited by this paper
• A Polymorphism in the CDKN1B Gene Is Associated with Increased Risk of Hereditary Prostate Cancer

  2004cited by this paper
• Novel p27kip1 C-Terminal Scatter Domain Mediates Rac-Dependent Cell Migration Independent of Cell Cycle Arrest Functions

  2003cited by this paper
• Recessive transmission of a multiple endocrine neoplasia syndrome in the rat.

  2002cited by this paper
• Glycoprotein glycosylation and cancer progression.

  1999cited by this paper
• The murine gene p27Kip1 is haplo-insufficient for tumour suppression

  1998cited by this paper
• Mutation and expression analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in pituitary tumors.

  1998cited by this paper
• Molecular analysis of p21 and p27 genes in human pituitary adenomas.

  1997cited by this paper
• Transforming growth factor-beta, transforming growth factor-beta receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries.

  1997cited by this paper
• A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice.

  1996cited by this paper
• Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors.

  1996cited by this paper
• Molecular analysis of the cyclin‐dependent kinase inhibitor family: p16(CDKN2/MTS1/INK4A), p18(INK4C) and p27(Kip1) genes in neuroblastomas

  1996cited by this paper
• Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1).

  1996cited by this paper
• Alterations of the p27KIP1 gene in non-Hodgkin's lymphomas and adult T-cell leukemia/lymphoma.

  1995cited by this paper
• Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27.

  1995cited by this paper
• Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies.

  1995cited by this paper
• JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM

  1953cited by this paper

• A Rare Case of Acromegaly and Prolactinoma in MEN4 Caused by a CDKN1B Mutation

  2026cites this paper
• p27Kip1 and Tumors: Characterization of CDKN1B Variants Identified in MEN4 and Breast Cancer

  2025cites this paper
• Appendiceal NET in an 18-year-old woman, the youngest case of MEN4 with neuroendocrine manifestation: case report and review of the current literature

  2024influential citation
• Genetic diagnosis in acromegaly and gigantism: From research to clinical practice.

  2024cites this paper
• Beyond MEN1, when to think about MEN4? Retrospective study on 5600 patients in the French population & literature review.

  2024cites this paper
• Challenges in molecular diagnosis of multiple endocrine neoplasia

  2024cites this paper
• An Update on the Genetic Drivers of Corticotroph Tumorigenesis

  2024cites this paper
• Pituitary Neuroendocrine Tumors in Multiple Endocrine Neoplasia

  2024cites this paper
• Multiple endocrine neoplasia type 4 (MEN4): a thorough update on the latest and least known men syndrome

  2023cites this paper
• The clinical and therapeutic profiles of prolactinomas associated with germline pathogenic variants in the aryl hydrocarbon receptor interacting protein (AIP) gene

  2023cites this paper
• Preclinical evaluation of CDK4 phosphorylation predicts high sensitivity of malignant pleural mesotheliomas to CDK4/6 inhibition

  2022cites this paper
• Case Report: New CDKN1B Mutation in Multiple Endocrine Neoplasia Type 4 and Brief Literature Review on Clinical Management

  2022cites this paper
• Multiple endocrine neoplasia type 4: a new member of the MEN family

  2022cites this paper
• Preclinical evaluation of CDK4 phosphorylation predicts high sensitivity of pleural mesotheliomas to CDK4/6 inhibition

  2022cites this paper
• Novel germline variants of CDKN1B and CDKN2C identified during screening for familial primary hyperparathyroidism

  2022cites this paper
• Germline CDKN1B variant type and site are associated with phenotype in MEN4.

  2022cites this paper
• Genetics of Cushing's disease

  2022cites this paper
• MEN4, the MEN1 Mimicker: A Case Series of three Phenotypically Heterogenous Patients With Unique CDKN1B Mutations

  2022cites this paper
• Pathophysiology and genetics in pituitary tumors

  2021cites this paper
• Multiple Endocrine Neoplasia-Type 4 (MEN4) and Other MEN1-Like Syndromes

  2021cites this paper
• Genetics of Pituitary Gigantism: Syndromic and Nonsyndromic Causes

  2021cites this paper
• Neuroendocrine Neoplasms with Peculiar Biology and Features: MEN1, MEN2A, MEN2B, MEN4, VHL, NF1

  2021cites this paper
• CDKN1B (p27) defects leading to pituitary tumors

  2021cites this paper
• Gigantism: clinical diagnosis and description

  2021cites this paper
• Comparative Analysis of Promoters and Enhancers in the Pituitary Glands of the Bama Xiang and Large White Pigs

  2021cites this paper
• Clinical Profile and Mutations Associated with Multiple Endocrine Neoplasia-Type1 (MEN1) and Their First-Degree Relatives at Risk of Developing MEN1: A Prospective Study

  2021cites this paper
• Preclinical drug studies in MEN1-related neuroendocrine neoplasms (MEN1-NENs).

  2020cites this paper
• Germline CDKN1B loss-of-function variants cause pediatric Cushing's disease with or without an MEN4 phenotype.

  2020cites this paper
• Sindrome delle neoplasie endocrine multiple di tipo 4

  2020cites this paper
• CDKN1B Gene

  2020cites this paper
• Integrated multi-omics profiling of nonfunctioning pituitary adenomas

  2020cites this paper
• Retinoblastoma co-repressor 1 (RB) and cyclin-dependent kinase inhibitor (CDKN) as a multi-gene panel for differentiating pulmonary from non-pulmonary origin in metastatic neuroendocrine carcinomas.

  2020cites this paper
• Update on the Genetics of Pituitary Tumors.

  2020cites this paper
• Inherited syndromes involving pancreatic neuroendocrine tumors.

  2020cites this paper
• GENETICS IN ENDOCRINOLOGY: Somatic and germline mutations in the pathogenesis of pituitary adenomas.

  2019cites this paper
• Germline and mosaic mutations causing pituitary tumours: genetic and molecular aspects.

  2019cites this paper
• Three Novel MEN1 Variants in AIP-Negative Familial Isolated Pituitary Adenoma Patients

  2019cites this paper
• Aggressive and Malignant Prolactinomas

  2019cites this paper
• Clinical Features of Multiple Endocrine Neoplasia Type 4: Novel Pathogenic Variant and Review of Published Cases

  2019cites this paper
• Spotlight on telotristat ethyl for the treatment of carcinoid syndrome diarrhea: patient selection and reported outcomes

  2019cites this paper
• Genetics of Pituitary Tumours.

  2019cites this paper
• The Genetics of Pituitary Adenomas

  2019cites this paper
• Multiple Endocrine Neoplasia-Type 4 (MEN4) and Other MEN1-Like Syndromes

  2019cites this paper
• University of Southern Denmark Clinical Features of Multiple Endocrine Neoplasia Type 4 Novel Pathogenic Variant and Review of Published Cases

  2019cites this paper
• The causes and consequences of pituitary gigantism

  2018cites this paper
• Genomic Alterations in Sporadic Pituitary Tumors

  2018cites this paper
• Genetics of Pituitary Tumor Syndromes

  2017cites this paper
• Genetic Aspects of Pituitary Adenomas.

  2017cites this paper
• Metabolic changes in patients with familial pituitary adenomas associated with mutations in the AIP gene

  2017cites this paper
• Sporadic pituitary adenomas: the role of germline mutations and recommendations for genetic screening

  2017cites this paper
• p27Kip1 and human cancers: A reappraisal of a still enigmatic protein.

  2017cites this paper
• Multiple Endocrine Neoplasia and Hyperparathyroid-Jaw Tumor Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood

  2017influential citation
• MEN4 and CDKN1B mutations: the latest of the MEN syndromes.

  2017cites this paper
• Screening for genetic causes of growth hormone hypersecretion.

  2016cites this paper
• New Insights Into the Mechanism of COP9 Signalosome-Cullin-RING Ubiquitin-Ligase Pathway Deregulation in Urological Cancers.

  2016cites this paper
• T2 weighted MRI and Histopathology as Markers for Response to Somatostatin Analogues in Acromegaly

  2016cites this paper
• Landscape of Genomic Alterations in Pituitary Adenomas

  2016cites this paper
• Emerging Histopathological and Genetic Parameters of Pituitary Adenomas: Clinical Impact and Recommendation for Future WHO Classification

  2016cites this paper
• Chapter 4 – Functioning Pituitary Adenomas

  2016cites this paper
• Decoding the genetic basis of Cushing's disease: USP8 in the spotlight.

  2015cites this paper
• The Multiple Endocrine Neoplasia Syndromes

  2015cites this paper
• Molecular genetic advances in pituitary tumor development

  2015cites this paper
• New potential targets for treatment of Cushing’s disease: epithelial growth factor receptor and cyclin-dependent kinases

  2015cites this paper
• 15 YEARS OF PARAGANGLIOMA: The association of pituitary adenomas and phaeochromocytomas or paragangliomas.

  2015cites this paper
• Genetic mutations in sporadic pituitary adenomas—what to screen for?

  2015cites this paper
• Pituitary gigantism: Causes and clinical characteristics.

  2015cites this paper
• Early onset acromegaly associated with a novel deletion in CDKN1B 5′UTR region

  2015cites this paper
• Familial isolated pituitary adenomas (FIPA) and mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.

  2015cites this paper
• The Insulin-Like Growth Factor System in Obesity, Insulin Resistance and Type 2 Diabetes Mellitus

  2014cites this paper
• The role of genetic and epigenetic changes in pituitary tumorigenesis.

  2014cites this paper
• The Role of Genetic and Epigenetic Changes in Pituitary Tumorigenesis

  2014cites this paper
• Precursor lesions of endocrine system neoplasms

  2013cites this paper
• Multiple endocrine neoplasia type 4.

  2013cites this paper
• Geographical information system (GIS) as a new tool to evaluate epidemiology based on spatial analysis and clinical outcomes in acromegaly

  2013cites this paper
• Familial Pituitary Adenomas

  2013cites this paper
• Multiple endocrine neoplasia syndromes associated with mutation of p27

  2013cites this paper
• Pituitary adenomas: Surgery and radiotherapy in the age of molecular diagnostics and pathology.

  2013cites this paper
• Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.

  2013cites this paper
• Overview of genetic testing in patients with pituitary adenomas.

  2012cites this paper
• Familial isolated pituitary adenomas: An emerging clinical entity

  2012cites this paper
• 3 Gigantism: clinical diagnosis and description

  year unknowncites this paper